HK Winhealth Pharma

Winhealth Pharma is a leading specialty pharmaceutical company dedicated to bringing innovative therapies to patients with rare diseases and other unmet medical needs in Greater China. Headquartered in Hong Kong and Hangzhou, the company operates a comprehensive platform that spans clinical development, regulatory affairs, and commercialization. Winhealth has built a robust and diverse portfolio through strategic in-licensing partnerships with global biopharmaceutical leaders such as Kyowa Kirin, Recordati, and Shionogi. Their therapeutic focus includes rare diseases, oncology, hematology, nephrology, and anti-infectives. Key commercial products include treatments for X-linked hypophosphatemia, mycosis fungoides, and hyperammonemia. The company is recognized as a pioneer in the rare disease space in China, actively participating in the development of the country's orphan drug ecosystem.